Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis

Pavlidis N (2007) Forty years experience of treating cancer of unknown primary. Acta Oncol 46:592–601

Pavlidis N, Briasoulis E, Hainsworth J, Greco FA (2003) Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer 39:1990–2005

Rohren EM, Turkington TG, Coleman RE (2004) Clinical applications of PET in oncology. Radiology 231:305–332

Sève P, Billotey C, Broussolle C, Dumontet C, Mackey JR (2007) The role of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in disseminated carcinoma of unknown primary site. Cancer 109:292–299

Rusthoven KE, Koshy M, Paulino AC (2004) The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor. Cancer 101:2641–2649

Delgado-Bolton RC, Fernández-Pérez C, González-Maté A, Carreras JL (2003) Meta-analysis of the performance of 18F-FDG PET in primary tumor detection in unknown primary tumors. J Nucl Med 44:1301–1314

Blodgett TM, Meltzer CC, Townsend DW (2007) PET/CT: form and function. Radiology 242:360–385

Von Schulthess GK, Steinert HC, Hany TF (2006) Integrated PET/CT: current applications and future directions. Radiology 238:405–422

Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J (2003) The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 3:25

Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, Kleijnen J (2006) Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol 6:9

Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A (2006) Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 6:31

Fencl P, Belohlavek O, Skopalova M, Jaruskova M, Kantorova I, Simonova K (2007) Prognostic and diagnostic accuracy of [18F]FDG-PET/CT in 190 patients with carcinoma of unknown primary. Eur J Nucl Med Mol Imaging 34:1783–1792

Nassenstein K, Veit-Haibach P, Stergar H et al (2007) Cervical lymph node metastases of unknown origin: primary tumor detection with whole-body positron emission tomography/computed tomography. Acta Radiol 23:1–8

Fleming AJ Jr, Smith SP Jr, Paul CM et al (2007) Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients. Laryngoscope 117:1173–1179

Bruna C, Journo A, Netter F et al (2007) On the interest of PET with 18F-FDG in the management of cancer of unknown primary (CUP). Med Nucl 31:242–249

Wartski M, Le Stanc E, Gontier E et al (2007) In search of an unknown primary tumor presenting with cervical metastases: performance of hybrid FDG-PET-CT. Nucl Med Commun 28:365–371

Paul SA, Stoeckli SJ, von Schulthess GK, Goerres GW (2007) FDG PET and PET/CT for the detection of the primary tumor in patients with cervical non-squamous cell carcinoma metastasis of an unknown primary. Eur Arch Otorhinolaryngol 264:189–195

Ambrosini V, Nanni C, Rubello D et al (2006) 18F-FDG PET/CT in the assessment of carcinoma of unknown primary origin. Radiol Med (Torino) 111:1146–1155

Schneider K, Hrasky A, Aschoff P, Bihl H, Hagen R (2006) Significance of PET and integrated PET/CT in the diagnostics of occult primary tumors. Laryngorhinootologie 85:819–823

Fakhry N, Barberet M, Lussato D et al (2006) Role of [18F]-FDG PET-CT in the management of the head and neck cancers. Bull Cancer 93:1017–1025

Schneider K, Aschoff P, Bihl H, Hagen R (2006) The integrated PET/CT: technological advance in diagnostics of head and neck recurrencies and CUP? Laryngorhinootologie 85:179–183

Pelosi E, Pennone M, Deandreis D, Douroukas A, Mancini M, Bisi G (2006) Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site. Q J Nucl Med Mol Imaging 50:15–22

Maldonado A, Gonzalez Alenda J (2006) The anatomicometabolic PET-CT in carcinoma of unknown primary site. Oncologia (Spain) 29:93–94

Fakhry N, Jacob T, Paris J et al (2006) Contribution of 18-F-FDG PET for detection of head and neck carcinomas with an unknown primary tumor. Ann Otolaryngol Chir Cervicofac 123:17–25

Zanation AM, Sutton DK, Couch ME, Weissler MC, Shockley WW, Shores CG (2005) Use, accuracy, and implications for patient management of [18F]-2-fluorodeoxyglucose-positron emission/computerized tomography for head and neck tumors. Laryngoscope 115:1186–1190

Nanni C, Rubello D, Castellucci P et al (2005) Role of 18F-FDG PET-CT imaging for the detection of an unknown primary tumor: preliminary results in 21 patients. Eur J Nucl Med Mol Imaging 32:589–592

Freudenberg LS, Fischer M, Antoch G et al (2005) Dual modality of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical carcinoma of unknown primary. Med Princ Pract 14:155–160

Syed R, Bomanji JB, Nagabhushan N et al (2005) Impact of combined (18)F-FDG PET/CT in head and neck tumors. Br J Cancer 92:1046–1050

Gutzeit A, Antoch G, Kühl H et al (2005) Unknown primary tumors: detection with dual-modality PET/CT – initial experience. Radiology 234:227–234

Rödel R, Straehler-Pohl HJ, Palmedo H et al (2004) PET/CT imaging in head and neck tumors. Radiologe 44:1055–1059

Blaszyk H, Hartmann A, Bjornsson J (2007) Cancer of unknown primary origin: a decade of experience in a community-based hospital. Am J Surg 194:833–837

Al-Brahim N, Ross C, Carter B, Chorneyko K (2005) The value of postmortem examination in cases of metastasis of unknown origin-20-year retrospective data from a tertiary care center. Ann Diagn Pathol 9:77–80

Mayordomo JI, Guerra JM, Guijarro C et al (1993) Neoplasms of unknown primary site: a clinicopathological study of autopsied patients. tumori 79:321–324

Le Chevalier T, Cvitkovic E, Caille P et al (1988) Early metastatic cancer of unknown primary origin at presentation. A clinical study of 302 consecutive autopsied patients. Arch Intern Med 148:2035–2039

Werner JA, Dünne AA, Myers JN (2003) Functional anatomy of the lymphatic drainage system of the upper aerodigestive tract and its role in metastasis of squamous cell carcinoma. Head Neck 25:322–332

Mawlawi O, Pan T, Macapinlac HA (2006) PET/CT imaging techniques, considerations, and artifacts. J Thorac Imaging 21:99–110

Truong MT, Pan T, Erasmus JJ (2006) Pitfalls in integrated CT-PET of the thorax: implications in oncologic imaging. J Thorac Imaging 21:111–122

Blodgett TM, Fukui MB, Snyderman CH et al (2005) Combined PET-CT in the head and neck: part 1. Physiologic, altered physiologic, and artifactual FDG uptake. Radiographics 25:897–912

Lim HS, Yoon W, Chung TW et al (2007) FDG PET/CT for the detection and evaluation of breast diseases: usefulness and limitations. Radiographics 27(suppl 1):S197–S213

Fischbach F, Knollmann F, Griesshaber V, Freund T, Akkol E, Felix R (2003) Detection of pulmonary nodules by multislice computed tomography: improved detection rate with reduced slice thickness. Eur Radiol 13:2378–2383

Ay MR, Zaidi H (2006) Assessment of errors caused by X-ray scatter and use of contrast medium when using CT-based attenuation correction in PET. Eur J Nucl Med Mol Imaging 33:1301–1313

Antoch G, Freudenberg LS, Egelhof T et al (2002) Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans. J Nucl Med 43:1339–1342

Lauenstein TC, Semelka RC (2006) Emerging techniques: whole-body screening and staging with MRI. J Magn Reson Imaging 24:489–498

Runge VM (2001) Safety of magnetic resonance contrast media. Top Magn Reson Imaging 12:309–314

Plathow C, Walz M, Lichy MP et al (2008) Cost considerations for whole-body MRI and PET/CT as part of oncologic staging. Radiologe 48:384–396

Eustace S, Tello R, DeCarvalho V, Carey J, Melhem E, Yucel EK (1998) Whole body turbo STIR MRI in unknown primary tumor detection. J Magn Reson Imaging 8:751–753

Brauck K, Zenge MO, Vogt FM et al (2008) Feasibility of whole-body MR with T2- and T1-weighted real-time steady-state free precession sequences during continuous table movement to depict metastases. Radiology 246:910–916

Kwee TC, Takahara T, Ochiai R, Nievelstein RAJ, Luijten PR (2008) Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol 18:1937–1952

Schapira DV, Jarrett AR (1995) The need to consider survival, outcome, and expense when evaluating and treating patients with unknown primary carcinoma. Arch Intern Med 155:2050–2054

Raber MN, Faintuch J, Abbruzzese JL, Sumrall C, Frost P (1991) Continuous infusion 5-fluorouracil, etoposide and cis-diamminedichloroplatinum in patients with metastatic carcinoma of unknown primary origin. Ann Oncol 2:519–520

Haas I, Hoffmann TK, Engers R, Ganzer U (2002) Diagnostic strategies in cervical carcinoma of an unknown primary (CUP). Eur Arch Otorhinolaryngol 259:325–333